, 2006 FCA 421 (Clopidogrel*)
Justice Evans; Justice Noël; Justice Richard - 2006-12-22
Read full decision. Automatically generated summary:
This is an appeal from the judgment of Shore J. of the Federal Court (2005 FC 390) prohibiting the Respondent Minister of Health from issuing a Notice of Compliance (“NOC”) to Apotex Inc. (“Apotex” or “the appellant”), pursuant to the Patented Medicines (Notice of Compliance) Regulations, SOR/93-133 (“NOC Regulations”), with respect to its 75 mg clopidogrel bisulfate tablets until the expiry of Canadian Letters Patent No. 1,336,777 (“the ‘777 Patent”).
Decision relates to:
- A-168-05 - APOTEX INC. v. SANOFI-SYNTHELABO CANADA INC. ET AL